Dearmi Tablet, 21 Tablets
GC Biopharma Corp.
(주)녹십자Dearmi Tablet, 21 Tablets What it is used for
Take 1 tablet a day for 21 days in the indicated order, then have a 7-day drug-free interval. It is desirable to take it at the same time every day if possible. Menstruation occurs during the 7-day drug-free interval and usually starts within 2-3 days after taking the last tablet. If you continue taking this medicine, start taking tablets from a new pack after the 7-day drug-free interval, and menstruation may not have ended before starting the new pack. For other details, refer to the detailed approved information.
Show the Korean original
1일 1정씩 21일간 표시된 순서에 따라 복용하고, 7일간 휴약합니다. 복용시간은 가능하면 매일 같은 시간에 복용하는 것이 바람직합니다. 7일의 휴약기간 동안 월경이 나타나며 대개 정제의 마지막 복용 후 2~3일 내에 시작됩니다. 이 약을 계속 복용할 경우 7일간 휴약 후 새 포장의 정제로 복용을 시작하며 새로운 포장을 시작하기 전에 월경이 끝나지 않을 수도 있습니다. 기타 자세한 사항은 허가사항 상세정보를 참고하십시오.
This information is provided for reference and is not medical advice. Source: Korea Ministry of Food and Drug Safety (MFDS). Where an English translation is shown, the Korean original is available above and takes precedence.
Dearmi Tablet, 21 Tablets How to take it
Take 1 tablet a day for 21 days in the indicated order, then have a 7-day drug-free interval. It is desirable to take it at the same time every day if possible. Menstruation occurs during the 7-day drug-free interval and usually starts within 2-3 days after taking the last tablet. If you continue taking this medicine, start taking tablets from a new pack after the 7-day drug-free interval, and menstruation may not have ended before starting the new pack. For details, refer to the detailed approved information.
Show the Korean original
1일 1정씩 21일간 표시된 순서에 따라 복용하고, 7일간 휴약합니다. 복용시간은 가능하면 매일 같은 시간에 복용하는 것이 바람직합니다. 7일의 휴약기간 동안 월경이 나타나며 대개 정제의 마지막 복용 후 2~3일 내에 시작됩니다. 이 약을 계속 복용할 경우 7일간 휴약 후 새 포장의 정제로 복용을 시작하며 새로운 포장을 시작하기 전에 월경이 끝나지 않을 수도 있습니다. 자세한 사항은 허가사항 상세정보를 참고하십시오.
This information is provided for reference and is not medical advice. Source: Korea Ministry of Food and Drug Safety (MFDS). Where an English translation is shown, the Korean original is available above and takes precedence.
Dearmi Tablet, 21 Tablets Important warnings
Women taking oral contraceptives should refrain from smoking because serious cardiovascular risks such as thrombosis may increase. Smokers 35 years and older should not take this medicine.
Show the Korean original
혈전증과 같은 심각한 심혈관계 위험이 증가할 수 있어 경구피임제를 복용하는 여성은 흡연을 삼갑니다. 35세 이상 흡연자는 이 약을 복용하지 마십시오.
This information is provided for reference and is not medical advice. Source: Korea Ministry of Food and Drug Safety (MFDS). Where an English translation is shown, the Korean original is available above and takes precedence.
Dearmi Tablet, 21 Tablets Precautions
Patients with hypersensitivity to this medicine, tumors (e.g., breast cancer, endometrial cancer, pituitary tumor), thrombotic arteriovenous phlebitis, thromboembolism, cerebrovascular or coronary artery disease, undiagnosed abnormal genital bleeding, severe hypertension, severe liver disorder, Dubin-Johnson syndrome, Rotor syndrome, jaundice, cholestasis (bile stasis), hepatitis, sickle cell anemia, severe diabetes, severe hyperlipidemia, hyperlipoproteinemia, porphyria, metabolic disorders, persistent itching during pregnancy, herpes gestationis, pemphigoid, otosclerosis, pregnant women or women who may be pregnant and breastfeeding women, galactorrhea, hyperprolactinemia, migraine accompanied by aura such as scotoma or star-shaped scintillations, pancreatitis, headache accompanied by focal neurological symptoms such as aura, hepatitis C, congenital or acquired hypercoagulopathy, smokers 35 years and older, or patients with genetic problems such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should not take this medicine. Before taking this medicine, smokers, patients with hypertension, obese patients, women 40 years and older, patients with epilepsy, migraine, patients with a history of arterial disease or varicose veins, systemic lupus erythematosus, patients with a history of breast cancer, depression or a history of it, patients with heart or kidney failure, patients with atypical hyperplastic mastopathy, patients with a history of breast nodules, patients with heart valve disease or arterial fibrillation (quivering), patients with a history of hyperlipidemia, patients with a history of gallbladder (gall) disease or cholelithiasis, patients with endometriosis, patients with asthma or chloasma, patients with peripheral blood circulation disorder, or patients with diabetes should consult a doctor or pharmacist. This medicine does not prevent HIV infection (AIDS) or other sexually transmitted diseases. If you have a severe gastrointestinal disease, absorption may be incomplete, so use an additional contraceptive method. This medicine does not apply to women before menarche or women after menopause. For other details, refer to the detailed approved information.
Show the Korean original
이 약에 과민증 환자, 종양(예: 유방암, 자궁내막암, 뇌하수체 종양), 혈전성동맥정맥염, 혈전색전증, 뇌혈관 또는 관상동맥질환, 진단하지 않은 비정상적인 생식기 출혈, 중증 고혈압, 중증 간장애, 두빈-존슨증후군, 로터증후군, 황달, 담즙울체(쓸개즙정체), 간염, 겸상적혈구빈혈, 중증 당뇨병, 중증 고지혈증, 고지단백혈증, 포르피린증, 대사장애, 임신 중 지속적인 가려움, 임신포진, 유천포창, 이경화증, 임부 또는 임신하고 있을 가능성이 있는 여성 및 수유부, 유루증, 고프로락틴혈증, 시야불능부위, 성형섬광(星型閃光) 등의 전조를 수반하는 편두통, 췌장염, 전조와 같은 국소성 신경학적 증상을 수반하는 두통, C형간염, 선천성 또는 후천성 과응고병증, 35세 이상 흡연자, 갈락토오스 불내성, Lapp 유당분해효소 결핍증 또는 포도당-갈락토오스 흡수장애 등의 유전적인 문제가 있는 환자는 이 약을 복용하지 마십시오. 이 약을 복용하기 전에 흡연자, 고혈압, 비만자, 40세 이상의 여성, 간질 환자, 편두통, 동맥질환 또는 정맥류 경험자, 전신성 홍반성 루푸스, 유방암 경험자, 우울증 및 경험자, 심ㆍ신부전 환자, 비전형적 과다증식된 유선병증 환자, 유방결절 경험자, 심장판막질환, 동맥세동(잔떨림) 환자, 고지혈증 경험자, 담낭(쓸개)질환 및 담석증 경험자, 자궁내막증 환자, 천식 또는 기미 환자, 말초혈액순환장애 환자, 당뇨병 환자는 의사 또는 약사와 상의하십시오. 이 약은 HIV감염(에이즈) 및 다른 성병의 예방 기능은 없습니다. 심한 위장관계질환이 있는 경우, 흡수가 불완전할 수 있으므로 부가적인 피임법을 사용하십시오. 이 약은 초경 전 여성과 폐경 후 여성에 대해 적용되지 않습니다. 기타 자세한 사항은 허가사항 상세정보를 참고하십시오.
This information is provided for reference and is not medical advice. Source: Korea Ministry of Food and Drug Safety (MFDS). Where an English translation is shown, the Korean original is available above and takes precedence.
Dearmi Tablet, 21 Tablets Interactions
Do not take together with hepatitis C direct-acting antiviral agents, phenytoin, barbiturates, primidone, carbamazepine, rifampicin, rufinamide, aprepitant, bosentan, efavirenz, oxcarbazepine, topiramate, felbamate, griseofulvin and St. John's wort, hyperlipidemia drugs, or antibiotics. Do not take together with grapefruit juice. For other details, refer to the detailed approved information.
Show the Korean original
C형 간염 직접 작용 항바이러스제, 페니토인, 바르비탈류, 프리미돈, 카르바마제핀, 리팜피신, 루피나미드, 아프레피탄트, 보센탄, 에파비렌즈, 옥스카르바제핀, 토피라메이트, 펠바메이트, 그리세오풀빈과 세인트존스풀, 고지혈증약물, 항생제와 함께 복용하지 마십시오. 자몽주스와 함께 복용하지 마십시오. 기타 자세한 사항은 허가사항 상세정보를 참고하십시오.
This information is provided for reference and is not medical advice. Source: Korea Ministry of Food and Drug Safety (MFDS). Where an English translation is shown, the Korean original is available above and takes precedence.
Dearmi Tablet, 21 Tablets Side effects
If symptoms of arterial thromboembolism, venous thromboembolism, cerebrovascular accident, vascular occlusion, or myocardial infarction occur, stop taking it immediately and consult a doctor or pharmacist. Genitourinary symptoms (intermenstrual bleeding, changes in menstrual flow and amenorrhea, etc.), breast symptoms (breast tension and enlargement, galactorrhea, breast pain, etc.), digestive system symptoms (nausea, vomiting, abdominal bloating, liver disorder, etc.), central nervous system symptoms (headache, migraine, depression, dizziness, etc.), skin symptoms (chloasma, acne, erythema multiforme, etc.), eye symptoms (visual impairment, changes in corneal refraction, etc.), hearing impairment, metabolic symptoms (sodium and fluid retention, etc.), weight changes, changes in appetite, etc. may occur. For other details, refer to the detailed approved information.
Show the Korean original
동맥혈전색전증, 정맥혈전색전증, 뇌혈관사고, 혈관폐쇄, 심근경색의 증상이 나타나는 경우 복용을 즉각 중지하고 의사 또는 약사와 상의하십시오. 비뇨생식기계 증상(월경외출혈, 월경량 변화 및 무월경 등), 유방 증상(유방긴장감 및 확대, 유루증, 유방통 등), 소화기계 증상(구역, 구토, 복부팽만감, 간장애 등), 중추신경계 증상(두통, 편두통, 우울증, 어지러움 등), 피부 증상(기미, 여드름, 다형성 홍반 등), 눈 증상(시각장애, 각막굴절변화 등), 청각장애, 대사 증상(나트륨 및 체액저류 등), 체중변화, 식욕변화 등이 나타날 수 있습니다. 기타 자세한 사항은 허가사항 상세정보를 참고하십시오.
This information is provided for reference and is not medical advice. Source: Korea Ministry of Food and Drug Safety (MFDS). Where an English translation is shown, the Korean original is available above and takes precedence.
Dearmi Tablet, 21 Tablets How to store it
Store at room temperature. Keep out of reach of children.
Show the Korean original
실온에서 보관하십시오. 어린이의 손이 닿지 않는 곳에 보관하십시오.
This information is provided for reference and is not medical advice. Source: Korea Ministry of Food and Drug Safety (MFDS). Where an English translation is shown, the Korean original is available above and takes precedence.
Pharmacy prices
All 4 pharmacies
- Lowest
- ₩5,000
- Average
- ₩5,750
- Highest
- ₩7,500
₩5,000
Updated 3 months ago